Sofiya A. Galkina - Concepedia

Author

Sofiya A. Galkina

University of California, San Francisco

Also Known As

S.A. Galkina, Sofiya A. Galkina

Publications

823

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco San Francisco General Hospital Stanford University ConjuChem (Canada)

About

Sofiya A. Galkina is an author at University of California, San Francisco specializing in immunology, medicine, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	669
2	Health Sciences	1	1	437
3	Biomolecular Engineering	1	1	62
4	Cell Biology	1	1	437
5	Clinical Immunology	1	1	96

Sofiya A. Galkina

Publications

815

Citations

H-Index

Page 1

	Year	Citations
Fetal and Adult Hematopoietic Stem Cells Give Rise to Distinct T Cell Lineages in Humans Jeff E. Mold, Shivkumar Venkatasubrahmanyam, Trevor D. Burt, Science Lymphocyte DevelopmentT-regulatory CellAdult Stem CellImmunologyImmune System	2010	437
Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rγ−/− (NSG) BLT mice Cheryl A. Stoddart, Ekaterina Maidji, Sofiya A. Galkina, Virology Primary ImmunodeficiencyClinical ImmunologyBlt MiceImmune Cell DevelopmentImmunodeficiencies	2011	96
Oral Administration of the Nucleoside EFdA (4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine) Provides Rapid Suppression of HIV Viremia in Humanized Mice and Favorable Pharmacokinetic Properties in Mice and the Rhesus Macaque Cheryl A. Stoddart, Sofiya A. Galkina, Pheroze Joshi, Antimicrobial Agents and Chemotherapy Excellent PotencyHiv ViremiaImmunologyPharmacotherapyAntiviral Drug	2015	74
Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor Cheryl A. Stoddart, Geneviève Nault, Sofiya A. Galkina, Journal of Biological Chemistry NeurovirologyMedicineHuman RetrovirusImmunologyAntiviral Response	2008	62
Validation of the SCID-hu Thy/Liv Mouse Model with Four Classes of Licensed Antiretrovirals Cheryl A. Stoddart, Cheryl A. Bales, Jennifer C. Bare, PLoS ONE	2007	58
Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection Lamin B. Cham, Laughing Bear Torrez Dulgeroff, Michal Caspi Tal, Cell Reports	2020	49
Efficacy of broadly neutralizing monoclonal antibody PG16 in HIV-infected humanized mice Cheryl A. Stoddart, Sofiya A. Galkina, Pheroze Joshi, Virology	2014	25
Preexposure Prophylaxis with Albumin-Conjugated C34 Peptide HIV-1 Fusion Inhibitor in SCID-hu Thy/Liv Mice Cheryl A. Stoddart, Geneviève Nault, Sofiya A. Galkina, Antimicrobial Agents and Chemotherapy	2012	14

Page 1